Contraception is the single most powerful technology ever introduced into the formation of romantic partnerships, and its distribution determines, at the collective level, who marries, who stays married, who has children, when, and with whom. This is not a metaphor. It is the conclusion of fifty years of economics, sociology, and public health research, most consequentially Claudia Goldin and Lawrence Katz's "power of the pill" papers showing that oral contraceptive access in the 1960s and 1970s drove women's enrollment in professional graduate programs, the timing of first marriage, and the trajectory of women's wages, with effects that compounded across generations. The pill, the IUD, the implant, the patch, the ring, emergency contraception, and the partner-side option of condoms and vasectomy together form an infrastructure on which modern partnership rests. Where the infrastructure is robust, partnerships form later, more deliberately, and with more equal terms between participants. Where the infrastructure is degraded, the older pattern reasserts itself: earlier marriage, more pregnancy-driven partnership formation, less educational and economic parity between partners, and a higher rate of partnership dissolution.

The collective situation in the United States in 2024 is unstable. Coverage of contraception under the Affordable Care Act, mandated by the Department of Health and Human Services in 2012 and contested through Burwell v. Hobby Lobby and Little Sisters of the Poor, technically remains in force but with significant exemptions for religious employers. Title X, the federal family-planning program that subsidizes contraception for low-income patients, has been pulled in opposite directions by successive administrations, with the Trump-era "gag rule" of 2019 eliminating Planned Parenthood as a Title X provider and the Biden administration reversing the rule in 2021. Roughly nineteen million American women live in contraceptive deserts, counties without a single full-range contraceptive provider. Pharmacist-prescribed birth control is available in some twenty-odd states but blocked in others. Over-the-counter Opill became available in 2023, the first OTC daily oral contraceptive in U.S. history, but at a price point of around twenty dollars a month uninsured.

Plan, the fourth law, asks what collective infrastructure absorbs the risks of partnership formation under uncertainty. Contraception is the canonical example. Without it, every act of intercourse carries a pregnancy risk that forces partnership decisions on a timeline biology dictates rather than one the participants chose. With it, those decisions become deliberate. The downstream effects on educational attainment, on labor force participation, on the gender wage gap, on divorce rates, on child outcomes, and on the bargaining position of women inside partnerships are massive and well-documented. Pamela Druckerman's comparative reporting on French and American partnership patterns has emphasized how universal contraception access in France produces a different texture of partnership formation, with later marriages, lower-stakes dating, and more egalitarian household economics, than the American patchwork generates.

The international comparison is sharp. The countries with the most robust contraception infrastructure, the Nordics, the Netherlands, France, also have the latest first-marriage ages, the most stable partnerships once formed, the highest female labor force participation, and the lowest teen pregnancy rates. The countries with the most restricted contraception access, including significant parts of the global south and increasingly parts of the United States, have the opposite profile. The variable that most cleanly predicts partnership outcomes at the population level is not income, religion, or education. It is reliable access to contraception. The relationship is causal and runs in the direction one would expect from first principles.

The current threats to American contraception access are not abstract. They include statutory and regulatory changes that could narrow ACA coverage, state-level proposals to restrict access to specific methods (particularly IUDs and emergency contraception, which are sometimes mischaracterized as abortifacient), and the longer-term legal exposure of Griswold v. Connecticut should the Supreme Court accept Justice Thomas's invitation in his Dobbs concurrence to reconsider it. The threats are uneven across states. The effects on partnership formation will be uneven in the same pattern. The country is in the process of running an unintentional natural experiment on what happens when half the population has reliable contraception access and the other half does not.

A serious collective response would treat contraception the way wealthy countries treat any other essential medical technology: universally accessible, low-cost, multiple-method, available without provider gatekeeping for the methods that do not require it, and stocked through every channel that gets people across geographic and economic barriers. The technologies exist. The cost is trivial compared to the cost of unintended pregnancies and their downstream effects. The political will to deliver the infrastructure has been intermittent and is currently in retreat. The partnership consequences will follow, decade by decade, in the demographic data.